InMed Pharmaceuticals Inc.
INM
$0.88
-$0.01-1.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.66M | -8.21M | -8.16M | -8.31M | -7.91M |
| Total Depreciation and Amortization | 575.40K | 546.50K | 534.80K | 555.60K | 576.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 244.00K | 185.00K | 197.60K | 229.00K | 219.30K |
| Change in Net Operating Assets | -576.90K | -68.00K | -337.20K | 509.30K | -174.90K |
| Cash from Operations | -7.42M | -7.55M | -7.77M | -7.02M | -7.29M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.73M | 12.13M | 13.16M | 4.36M | 1.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -771.70K | -829.30K | -883.90K | -264.50K | -249.40K |
| Cash from Financing | 10.96M | 11.30M | 12.27M | 4.10M | 1.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.54M | 3.75M | 4.50M | -2.92M | -6.12M |